CTTNBP2NL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.796000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.977600E-01
Normal-vs-Stage2
7.847600E-01
Normal-vs-Stage3
5.271400E-01
Normal-vs-Stage4
3.633800E-01
Stage1-vs-Stage2
8.757200E-01
Stage1-vs-Stage3
3.462000E-01
Stage1-vs-Stage4
2.483000E-01
Stage2-vs-Stage3
1.949590E-01
Stage2-vs-Stage4
7.053700E-02
Stage3-vs-Stage4
1.310830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.550400E-01
Normal-vs-AfricanAmerican
5.722400E-01
Normal-vs-Asian
6.899000E-01
Caucasian-vs-AfricanAmerican
2.581600E-01
Caucasian-vs-Asian
4.139200E-01
AfricanAmerican-vs-Asian
7.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.618000E-01
Normal-vs-Female
7.886800E-01
Male-vs-Female
3.817600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.920000E-01
Normal-vs-Age(41-60Yrs)
4.350400E-01
Normal-vs-Age(61-80Yrs)
8.700800E-01
Normal-vs-Age(81-100Yrs)
5.750400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.257600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.829400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.787400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.581600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.483800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.170800E-01
Normal-vs-Daily Drinker
8.312600E-01
Normal-vs-Weekly Drinker
7.211400E-01
Normal-vs-Occasional Drinker
5.453400E-01
Normal-vs-Social Drinker
8.300000E-01
Non Drinker-vs-Daily Drinker
8.767800E-01
Non Drinker-vs-Weekly Drinker
9.300800E-01
Non Drinker-vs-Occasional Drinker
3.456500E-02
Non Drinker-vs-Social Drinker
2.515600E-01
Daily Drinker-vs-Weekly Drinker
8.508600E-01
Daily Drinker-vs-Occasional Drinker
1.093810E-01
Daily Drinker-vs-Social Drinker
4.240800E-01
Weekly Drinker-vs-Occasional Drinker
8.807800E-02
Weekly Drinker-vs-Social Drinker
3.279600E-01
Occasional Drinker-vs-Social Drinker
4.545000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.732400E-01
Normal-vs-Grade 2
2.009800E-02
Normal-vs-Grade 3
2.544400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.354400E-04
Grade 1-vs-Grade 3
7.637600E-03
Grade 1-vs-Grade 4
2.732400E-01
Grade 2-vs-Grade 3
6.184600E-01
Grade 2-vs-Grade 4
2.009800E-02
Grade 3-vs-Grade 4
2.544400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.411600E-01
Normal-vs-NonDiabetic
9.339200E-01
Diabetic-vs-NonDiabetic
3.686400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.575400E-01
Normal-vs-NoPancreatitis
9.996000E-01
Pancreatitis-vs-NoPancreatitis
2.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.178600E-01
Normal-vs-N1
7.527600E-01
N0-vs-N1
1.478190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.000000E-01
Normal-vs-TP53-NonMutant
5.590000E-01
TP53-Mutant-vs-TP53-NonMutant
5.402900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
